A central question in molecular biology is how cells protect their chromosomes from damage during repeated cell division. At ...
Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of ...
Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results